Former Labor Leader Shelly Yachimovich Details Early Pancreatic Cancer Diagnosis
Translated & summarized from Vesty by baba
Former Israeli politician Shelly Yachimovich revealed how she detected her pancreatic cancer early due to bile duct obstruction causing abdominal pain. The article highlights the challenges of diagnosing this aggressive cancer and the improved survival rates with early detection and treatment.
The story in 5 lines · by baba
- Shelly Yachimovich discovered her pancreatic cancer early due to bile duct obstruction.
- Pancreatic cancer is often asymptomatic and difficult to detect early.
- Early diagnosis significantly improves survival rates for pancreatic cancer.
- New treatments like Daraxonrasib show promise for advanced stages.
- Key symptoms include jaundice, weight loss, and abdominal pain.
Former Labor party leader and Knesset member Shelly Yachimovich has shared details about how she discovered her pancreatic cancer at an early stage, a rarity for the often-undetected disease. In a Facebook post on August 30, Yachimovich explained that her symptoms began with abdominal pain, caused by a tumor obstructing her bile ducts and leading to inflammation. An ultrasound revealed the inflammation, and a subsequent CT scan identified the pancreatic tumor. "Usually, pancreatic cancer has no symptoms, and patients arrive late, when the tumor has already spread," she wrote, noting her fortunate diagnosis before metastasis. Pancreatic cancer is considered one of the most dangerous forms of cancer due to the pancreas's deep location in the abdomen, making early diagnosis difficult. Dr. Erez Hasnis, a senior physician at Rambam Health Care Campus in Haifa, explained that early-stage tumors often present with vague symptoms similar to other illnesses. While a blood test for the CA 19-9 marker exists, it lacks sufficient sensitivity and specificity for widespread screening. Potential warning signs include painless jaundice, dark urine, pale stools, unexplained weight loss, appetite loss, nausea, upper abdominal pain radiating to the back, and the sudden onset of adult-onset diabetes. Professor Irit Ben-Aharon, head of the Oncology Center at Rambam, cautioned that while diabetes is common, its sudden appearance in adulthood can sometimes be linked to pancreatic cancer.
Early detection significantly improves outcomes. Only about 15% of pancreatic cancer cases are diagnosed at a localized stage. When surgery is possible, combined with chemotherapy, the 5-year survival rate can reach 30-40%, a substantial increase from a decade ago. Yachimovich also mentioned Daraxonrasib, a new drug recently granted accelerated approval by the U.S. FDA, which has shown promise in extending median survival for patients with metastatic disease. Chemotherapy is crucial even after tumor removal to eliminate microscopic cells and prevent recurrence, according to Prof. Ben-Aharon. The article also provides a basic overview of the pancreas, pancreatic cancer, its aggressiveness, the importance of early diagnosis, common symptoms, diagnostic methods, the lack of universal screening, treatment options, and risk reduction strategies like avoiding smoking and maintaining a healthy weight.
Mentioned